CVS Health (CVS) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $2.09
- Estimate
- $1.65
- Surprise
- +26.6%
- Revenue (period 2026-09-30)
- $108.40B
- Score today
- 6.0/10
Revenue source: xbrl.
How the report landed
CVS Health (CVS) beat the $1.65 estimate with adjusted EPS of $2.09 — a large 26.6% upside surprise.
Coverage in the report window
- Elizabeth Warren Says CVS Is Still Trying To ‘Rip People Off’ With Planned Breakup as Mark Cuban Says Split ‘Changes Not — benzinga, 2026-11-05
- CVS Health Raises Its Outlook, Confirms Massive Breakup — benzinga, 2026-11-04
- CVS Health Q3 2026 Earnings Call Transcript — benzinga, 2026-11-04
Where TrendMatrix's rating stands now
TrendMatrix currently rates CVS Sell at 6.0/10; no pre/post engine snapshot brackets this report.
4 of the last 4 quarters beat the estimate; this quarter's +26.6% surprise compares with a +23.0% four-quarter average.
What argues against it
- Quality below floor (3.4 < 4.0)
- Momentum score 3.0/10 — below 4.5 minimum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $79.96
- Price target
- $103.97
- Stop
- $75.01
- Upside to target
- +30.0%
- Reward-to-risk
- 4.0:1
At 9.3× trailing and 9.4× forward earnings, consensus estimates imply little change in earnings power.
Risk check: RSI 28 — a level conventionally read as oversold; trading volume is running 3.4× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-11-05 — shown for context, not personalized investment advice.
CVS at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Healthcare Plans
- Market cap
- $102.27B
- P/E (fwd)
- 9.4
- P/E (ttm)
- 9.3
- 52-week range
- $69.51–$110.68
- Off 52-week high
- 27.8%
- RSI (14)
- 28
- Volume vs avg
- 3.44×
- Score today
- 6.0/10